These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4985943)

  • 1. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
    Villeneuve C; Ananth JV; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
    Edwards JG; Simpson GM
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):520-8. PubMed ID: 4971467
    [No Abstract]   [Full Text] [Related]  

  • 3. The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients.
    Lehmann HE; Ban TA; Lee H
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):36-7. PubMed ID: 4963021
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the clinical effects of timiperone, a new butyrophenone derivative, and haloperidol on schizophrenia using a double-blind technique.
    Kariya T; Shimazono Y; Itoh H; Mori A; Murasaki M; Sugano K; Toru M; Yamashita I
    J Int Med Res; 1983; 11(2):66-77. PubMed ID: 6133803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new butyrophenone derivative. AL-1021.
    Gallant DM; Bishop MP; Guerrero-Figueroa R; O'Meallie L
    Curr Ther Res Clin Exp; 1969 Jul; 11(7):456-9. PubMed ID: 4979994
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of antipsychotic activity of a butyrophenone analogue, lenperone (AHR 2277).
    Sathanathan GL; Angrist BM; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):844-7. PubMed ID: 4217252
    [No Abstract]   [Full Text] [Related]  

  • 7. A butyrophenone (haloperidol) for the treatment of institutionalized patients.
    Lapolla A; Nash LR
    Int J Neuropsychiatry; 1966 Apr; 2(2):129-34. PubMed ID: 5335397
    [No Abstract]   [Full Text] [Related]  

  • 8. Lenperone: a controlled evaluation in chronic schizophrenic patients.
    Mielke DH; Gallant DM; Kessler C; Roniger JJ
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):636-40. PubMed ID: 812640
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
    Hall WB; Vestre ND; Schiele BC; Zimmermann R
    Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
    Gallant DM; Bishop M; Guerrero-Figueroa R
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
    Gonier T; Schiele BC; Vestre ND
    Behav Neuropsychiatry; 1970; 2(3):47-9 passim. PubMed ID: 4913152
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of acute exacerbations in chronic schizophrenic patients.
    Towler ML; Wick PH
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:61-7. PubMed ID: 4860982
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with a new butyrophenone derivative (Buronil).
    Vangtorp A; Simmelsgaard H; Mellegaard M
    Acta Psychiatr Scand Suppl; 1968; 203():235-8. PubMed ID: 4881877
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 17. [Buronil (FG 5111)--a new butyrophenone derivative. A controlled clinical study on senile dementia and confusion].
    Simmelsgaard H; Mellergaard M; Vangtorp A
    Nord Med; 1967 Feb; 77(7):210-3. PubMed ID: 5336427
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of haloperidol in a "hard-core" chronic schizophrenic population.
    Lee H
    Psychosomatics; 1968; 9(5):267-71. PubMed ID: 4879677
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of thiothixene on schizophrenic symptoms in a long-term therapeutic scheme. Comparative study with butyrophenone derivative].
    Vianna Filho U; Muniz AF; Terra SO; Bueno JR
    J Bras Psiquiatr; 1971; 20(3):193-204. PubMed ID: 5164436
    [No Abstract]   [Full Text] [Related]  

  • 20. A pilot study of AL-449 in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):533-6. PubMed ID: 4971469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.